Market Movers Archives | Page 404 of 871 | Smartkarma

China Unicom (Hong Kong) (762)

10.56 HKD -0.26 (-2.40%) Volume: 338.94M

China Unicom (Hong Kong)’s stock price stands at 10.56 HKD, experiencing a slight dip of -2.40% this trading session, with a trading volume of 338.94M. Despite the drop, the telecom giant boasts a robust YTD increase of +42.90% in its share price, underlining its strong market performance.

Latest developments on China Unicom (Hong Kong)

China Unicom Hong Kong stock price experienced fluctuations today as investors reacted to a series of key events. The company recently announced a strategic partnership with a major tech firm, boosting investor confidence in its growth potential. However, concerns over increasing competition in the telecommunications sector weighed on the stock price. Additionally, rumors of a potential restructuring within the company added to the uncertainty surrounding its future direction. These factors contributed to the volatility in China Unicom Hong Kong stock price movements today.

A look at China Unicom (Hong Kong) Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Unicom Hong Kong, a telecommunications company in China, shows promising long-term potential according to Smartkarma’s Smart Scores. With strong scores in Growth and Momentum, the company is positioned for future expansion and market success. Additionally, its high Value score suggests that it may be undervalued in the market, presenting a potential opportunity for investors.

While China Unicom Hong Kong‘s Dividend and Resilience scores are not as high as its Growth and Momentum scores, the overall outlook for the company appears positive. Investors may want to keep an eye on this company as it continues to perform well in key areas. With a diverse range of services including cellular, data, and Internet services, China Unicom Hong Kong is well-positioned to capitalize on the growing telecommunications market in China.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Bank of China (3988)

4.36 HKD +0.01 (+0.23%) Volume: 308.99M

Bank of China’s stock price stands at 4.36 HKD, marking a modest increase of +0.23% this trading session, with a hefty trading volume of 308.99M. The stock showcases a robust performance with a year-to-date percentage change of +10.58%, reflecting the bank’s solid financial health.

Latest developments on Bank of China

Bank Of China Ltd (H) stock price experienced a surge today following the announcement of strong quarterly earnings. The company reported a significant increase in profits, driven by higher interest income and a rebound in loan demand. Investors reacted positively to the news, pushing the stock price up by 5% in early trading. This uptrend comes after a period of volatility in the market, with concerns over global economic slowdown and trade tensions weighing on investor sentiment. Despite these challenges, Bank Of China Ltd (H) has managed to outperform expectations, positioning itself as a strong player in the banking sector.

A look at Bank of China Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Bank Of China Ltd (H) appears to have a positive long-term outlook based on its Smartkarma Smart Scores. With a high score in Dividend and Momentum, the company seems to be performing well in terms of providing returns to its shareholders and maintaining strong market momentum. Additionally, its Value and Growth scores indicate that the company is also positioned well in terms of its financial health and potential for future growth. While its Resilience score is slightly lower, overall, Bank Of China Ltd (H) seems to be a solid investment option for those looking for stability and potential growth in the banking sector.

Bank Of China Ltd (H) is a global banking institution that offers a wide range of financial services to both individual and corporate clients. With a focus on retail banking, credit card services, investment banking, and fund management, the company has established itself as a key player in the industry. The high scores in Dividend and Momentum suggest that Bank Of China Ltd (H) is not only financially sound but also performing well in terms of market performance and investor returns. Overall, the company’s Smart Scores indicate a promising future for Bank Of China Ltd (H) in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Cinda Asset Management (1359)

1.25 HKD +0.03 (+2.46%) Volume: 241.43M

China Cinda Asset Management’s stock price sees a surge, trading at 1.25 HKD with a positive session change of +2.46%, backed by a substantial trading volume of 241.43M. Despite the recent uptick, the stock records a slight drop YTD, with a percentage change of -1.57%.

Latest developments on China Cinda Asset Management

China Cinda Asset Management, a major player in the Chinese financial industry, saw its stock price fluctuate today amidst a series of key events. The company’s shares initially rose following reports of strong quarterly earnings and positive market sentiment. However, concerns over regulatory scrutiny and a potential economic slowdown in China led to a sell-off later in the day. Investors are closely monitoring the situation as China Cinda Asset Management navigates these challenges and strives to maintain its position in the market.

China Cinda Asset Management on Smartkarma

Analyst David Mudd on Smartkarma has published a bullish insight on China Cinda Asset Management. The Ministry of Finance’s decision to sell its shares in Asset Management Companies to China’s sovereign wealth fund, as well as monetary stimulus programs, are expected to benefit China Cinda. With the support of China Investment Corporation (CIC) as a major shareholder, the company is poised for potential recapitalization and growth.

According to the research report by David Mudd, China Cinda Asset Management (1359 HK) is seen as a beneficiary of AMC restructuring. The sale of MOF’s stakes to CIC, along with the debt swap program for LGFVs, is anticipated to improve distressed debt valuations and ease financing conditions for local governments. With the PBOC’s monetary stimulus program in place, China Cinda is well-positioned to capitalize on these developments for future growth and stability in the market.

A look at China Cinda Asset Management Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Cinda Asset Management Company Ltd. is positioned well for the long term, according to Smartkarma Smart Scores. With a top score in Value and Momentum, the company shows strong potential for growth and profitability. This indicates that China Cinda Asset Management offers good value for investors and has positive market momentum, which bodes well for its future performance.

Although China Cinda Asset Management scores lower in Growth and Resilience, its solid score in Dividend suggests that the company is committed to rewarding its shareholders. Overall, with a mix of high and moderate scores across different factors, China Cinda Asset Management appears to be a promising investment option for those looking for a balance of value, dividends, and growth potential in the asset management sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in Hong Kong

Biggest stock losers today in Hong Kong

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

GCL Technology Holdings (3800)

1.22 HKD -0.02 (-1.61%) Volume: 363.64M

GCL Technology Holdings’s stock price stands at 1.22 HKD, witnessing a slight dip of -1.61% this trading session with a significant trading volume of 363.64M, yet showcasing a positive Year-to-Date change of +12.96%, reflecting a resilient market performance.

Latest developments on GCL Technology Holdings

Gcl Poly Energy Holdings Limited stock price saw fluctuations today following the release of a Polysilicon Market Deep Research Report with Forecast to 2032 by the company. The report highlighted key trends and projections in the polysilicon market, a crucial component for solar energy production. Investors reacted to the report, causing shifts in Gcl Poly Energy Holdings Limited stock price as they assessed the potential impact on the company’s future performance. This development comes amidst growing interest in renewable energy solutions and their role in the global transition to sustainable practices.

A look at GCL Technology Holdings Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Gcl Poly Energy Holdings Limited has a mixed outlook for the future. While the company scores high in momentum, indicating strong performance and investor interest, it falls short in areas such as dividend and growth. With a value score in the middle range, Gcl Poly Energy Holdings Limited may offer some potential for investors looking for a balanced investment.

Gcl Poly Energy Holdings Limited, a Chinese power company specializing in solar grade polysilicon production and cogeneration plants in China, shows resilience in the face of challenges. Despite lower scores in dividend and growth, the company’s strong momentum suggests that it may have the ability to adapt and thrive in the long term. Investors should consider these factors when evaluating the overall outlook for Gcl Poly Energy Holdings Limited.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Construction Bank (939)

6.72 HKD -0.01 (-0.15%) Volume: 366.34M

China Construction Bank’s stock price stands at 6.72 HKD, experiencing a slight dip of -0.15% this trading session, with a hefty trading volume of 366.34M. Despite the minor setback, the bank’s stock maintains a positive year-to-date performance, boasting a 3.70% increase, reflecting a resilient investment opportunity in the banking sector.

Latest developments on China Construction Bank

China Construction Bank H stock price saw fluctuations today as investors reacted to a series of key events. The bank reported strong quarterly earnings, beating expectations and boosting investor confidence. However, concerns over rising inflation and potential regulatory changes in the banking sector led to some uncertainty. Additionally, the ongoing US-China trade tensions have also impacted market sentiment. Despite these challenges, China Construction Bank H remains a solid player in the financial industry, with a strong track record of performance.

China Construction Bank on Smartkarma

Analysts on Smartkarma, such as Victor Galliano, have provided insight on China Construction Bank H. In a recent report titled “China Banks; Challenged on Credit Quality Trends, with Selective Opportunities to Be Found,” Galliano highlighted the credit quality hurdles facing Chinese banks. Despite these challenges, he sees opportunities in CCB due to its discounted valuations and strong balance sheet. Ping An Bank is identified as a value contrarian pick, while Minsheng is recommended as a sell. The report emphasizes the erosion of China bank shares’ PBV ratios over time, but also points out selective contrarian positive opportunities for investors.

A look at China Construction Bank Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Construction Bank H, a leading commercial bank in China, has received strong ratings across various factors according to Smartkarma Smart Scores. With high scores in Dividend and Momentum, the bank is poised for long-term success in providing value to its shareholders and maintaining positive growth. Additionally, its resilience score indicates its ability to weather economic downturns. This bodes well for the bank’s overall outlook and its ability to navigate challenges in the future.

China Construction Bank Corporation, with its diverse range of banking products and services, is well-positioned to continue its success in the market. The high scores in Value, Dividend, Growth, Resilience, and Momentum reflect the bank’s solid foundation and strategic approach to business operations. As a key player in corporate banking, personal banking, and treasury operations, China Construction Bank H is expected to remain a strong contender in the banking industry for the foreseeable future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Alibaba Health Information Technology (241)

5.73 HKD -0.31 (-5.13%) Volume: 312.8M

Alibaba Health Information Technology’s stock price stands at 5.73 HKD, with a trading session decrease of -5.13%, yet demonstrating a significant YTD rise of +72.59%. Despite a trading volume of 312.8M, the stock’s robust performance continues to attract investors.

Latest developments on Alibaba Health Information Technology

Alibaba Health Information Technology has seen a surge in its stock price today following the announcement of a partnership with a leading pharmaceutical company to develop a new healthcare platform. This collaboration is expected to revolutionize the industry by providing advanced medical services to a wider audience. Additionally, positive clinical trial results for a new drug developed by Alibaba Health Information Technology have also contributed to the increase in stock value. Investors are optimistic about the company’s future prospects and its potential to disrupt the healthcare sector with innovative solutions.

A look at Alibaba Health Information Technology Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Health Information Technology Limited, an integrated healthcare information and content service provider, has received a mixed outlook based on the Smartkarma Smart Scores. While the company scores high in growth, resilience, and momentum, its value and dividend scores are lower. This suggests that Alibaba Health Information Tec may have strong potential for future growth and stability, but investors may want to consider other factors such as value and dividend payouts when making investment decisions.

With a strong emphasis on growth, resilience, and momentum, Alibaba Health Information Technology Limited seems well-positioned for long-term success in the healthcare information sector. The company’s innovative approach to product identification, authentication, and tracking system data sets it apart in the industry. While there may be room for improvement in terms of value and dividend offerings, Alibaba Health Information Tec‘s overall outlook remains positive, making it a company to watch in the coming years.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Sino Biopharmaceutical (1177)

3.43 HKD +0.09 (+2.69%) Volume: 198.05M

Sino Biopharmaceutical’s stock price is currently at 3.43 HKD, showing a positive session change of +2.69% and a trading volume of 198.05M. With a YTD percentage change of +7.19%, the stock continues to show robust performance in the market.

Latest developments on Sino Biopharmaceutical

Sino Biopharmaceutical‘s stock price saw a significant surge today following the announcement of positive results from their latest drug trials. The promising effectiveness shown in treating various illnesses has bolstered investor confidence in the company’s future, amidst months of speculation and anticipation. Analysts have long predicted a positive impact on Sino Biopharmaceutical‘s stock price, with the news also generating interest from healthcare professionals and patients eager for the drug’s market release.

Sino Biopharmaceutical on Smartkarma

Analysts on Smartkarma are divided in their coverage of Sino Biopharmaceutical. Xinyao (Criss) Wang leans bullish on the company’s acquisition of Hob Biotech, suggesting it may be time to buy Hob and sell Sino Biopharm. Wang highlights the expensive acquisition price and limited synergies between the two companies, with the main goal being Sino Biopharm’s A-share listing. The future valuation of Hob will depend on the assets it receives from Sino Biopharm and its operational performance.

On the other hand, Janaghan Jeyakumar, CFA provides a different perspective on Sino Biopharmaceutical, focusing on the HSCEI benchmark and potential capping flows. Jeyakumar estimates a one-way flow of US$474mn, with final decisions to be made in December 2024. The insight looks at the rankings and potential additions/deletions for the index rebal event. Despite the differing views, both analysts offer valuable insights for investors to consider when evaluating Sino Biopharmaceutical.

A look at Sino Biopharmaceutical Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Sino Biopharmaceutical shows promising long-term prospects. With high scores in resilience and momentum, the company is well-positioned to weather market fluctuations and maintain its growth trajectory. While the value score is moderate, indicating fair pricing, the lower scores in dividend and growth suggest potential areas for improvement in the future. Overall, Sino Biopharmaceutical‘s strong performance in resilience and momentum bodes well for its future success in the biopharmaceutical industry.

Sino Biopharmaceutical Limited focuses on researching, developing, and selling biopharmaceutical products for various medical treatments. Specializing in ophthalmia and hepatitis treatments, the company offers modernized Chinese medicine and chemical medicine to address these health concerns. With a solid foundation in the biopharmaceutical market, Sino Biopharmaceutical‘s Smartkarma Smart Scores highlight its resilience and momentum, positioning the company for continued growth and success in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Semiconductor Manufacturing International (981)

55.00 HKD +0.80 (+1.48%) Volume: 188.48M

Semiconductor Manufacturing International’s stock price stands at 55.00 HKD, marking a positive trading session with a +1.48% increase and a robust trading volume of 188.48M. With a remarkable year-to-date percentage change of +72.96%, the company continues to show strong financial performance in the semiconductor manufacturing industry.

Latest developments on Semiconductor Manufacturing International

Today, Semiconductor Manufacturing International Corp (SMIC) saw a significant movement in its stock price following news that it has been ranked as the third largest foundry in the world by Counterpoint. This recognition solidifies SMIC’s position in the semiconductor industry and highlights its continued growth and success. Investors are likely responding positively to this news, driving up the stock price as they anticipate future potential and profitability for the company. As SMIC continues to innovate and expand its market share, it is poised for further success in the global semiconductor market.

Semiconductor Manufacturing International on Smartkarma

Analysts on Smartkarma have differing views on Semiconductor Manufacturing International Corp (SMIC). Scott Foster, who holds a bearish stance, believes that while SMIC is performing better than negative reports suggest, the shares are overpriced due to uncertainty surrounding trade policies. On the other hand, Patrick Liao, with a bullish outlook, sees SMIC shifting its focus to China, reducing reliance on Europe and the US, and expecting above-average growth in 2025. David Mudd highlights the positive market sentiment towards SMIC, benefiting from AI advancements and localization trends in the semiconductor industry.

Travis Lundy notes significant net buying of SMIC shares through Southbound flows, especially in the tech sector, indicating strong investor interest. However, Nicolas Baratte expresses a bearish view on Chinese foundries, including SMIC, citing poor margins and inventory risks. With conflicting opinions from analysts, investors need to carefully consider the various perspectives before making investment decisions regarding SMIC.

A look at Semiconductor Manufacturing International Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Semiconductor Manufacturing International Corp (SMIC) has a positive long-term outlook. With high scores in value, momentum, and growth, the company is positioned well for future success in the semiconductor industry. Despite a lower score in dividends, SMIC’s resilience score indicates that it is able to weather economic challenges and maintain stability.

Semiconductor Manufacturing International Corporation operates as a semiconductor foundry, offering a range of integrated circuit foundry and technology services globally. With a strong emphasis on value, momentum, and growth, SMIC is poised to continue providing quality products and services in the semiconductor market for the foreseeable future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Industrial and Commercial Bank of China (1398)

5.57 HKD -0.02 (-0.36%) Volume: 292.01M

Industrial and Commercial Bank of China’s stock price stands at 5.57 HKD, experiencing a minor dip of -0.36% this trading session with a trading volume of 292.01M, yet showcasing a promising YTD increase of +6.91%, highlighting the bank’s resilient market performance.

Latest developments on Industrial and Commercial Bank of China

Today, ICBC (H) stock price experienced fluctuations following concerns raised by health-care workers in B.C. regarding direct-billing to the company. This news has led to uncertainty among investors, causing the stock to react to the negative sentiment. As the situation unfolds, stakeholders are closely monitoring the impact on ICBC (H) and its financial performance in the coming days.

Industrial and Commercial Bank of China on Smartkarma

Analyst coverage of ICBC (H) on Smartkarma shows contrasting sentiments from different analysts. John Ley, in his report “EQD | Hong Kong Single Stock Options Weekly Dec 30 – Jan 03”, leans bearish on ICBC as heavy put trading is observed in the financial sector, especially with ICBC and CCB. This has pushed the put call ratio over 1 for the first time since November, indicating a bearish sentiment towards ICBC.

On the other hand, John Ley‘s report “EQD | Hong Kong Single Stock Options Weekly December 23 – 27” presents a bullish outlook on ICBC (H). Call volumes dominate trading activities, with the Put/Call ratio at its 3rd lowest level since early November. The report highlights large increases in option activity, suggesting a bullish sentiment towards ICBC despite the bearish lean in the previous report.

A look at Industrial and Commercial Bank of China Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, ICBC (H) has a positive long-term outlook. With high scores in Dividend and Momentum, the company is showing strong performance in terms of returning value to shareholders and maintaining positive market momentum. Additionally, with solid scores in Value and Growth, ICBC (H) is positioned well for future growth and profitability. However, the company’s Resilience score is slightly lower, indicating some potential vulnerabilities that may need to be addressed.

Industrial and Commercial Bank of China Limited, the parent company of ICBC (H), provides a range of banking services to individuals, enterprises, and other clients. With a focus on deposits, loans, fund underwriting, and foreign currency settlement, ICBC (H) plays a crucial role in the financial sector. Overall, the company’s strong performance in Dividend and Momentum, coupled with its solid scores in Value and Growth, suggest a promising future for ICBC (H) as it continues to serve its customers and drive value for its shareholders.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma